A new research perspective was published in Oncotarget’s Volume 15 on February 5, 2024, entitled, “Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.”
Having celiac disease and a thyroid condition sent her on a quest to become an empathetic doctor
A third-year med school student, Brianna Celix doesn’t get a lot of free time. Even with the one afternoon off she gets each week at
August 18, 2023